Decitabine activates type I interferon signaling to inhibit p53-deficient myeloid malignant cells.
Jiale WuYuntong LiJiaqi WuHuaxin SongYigang TangNi YanLili WuSujiang ZhangChunKang ChangMin LuPublished in: Clinical and translational medicine (2022)